Roche Holding AG (XSWX:ROG) NonCurrent Deferred Liabilities : CHF0 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Roche Holding AG NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Roche Holding AG's non-current deferred liabilities for the quarter that ended in Dec. 2023 was CHF0 Mil.

Roche Holding AG NonCurrent Deferred Liabilities Historical Data

The historical data trend for Roche Holding AG's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG NonCurrent Deferred Liabilities Chart

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Roche Holding AG NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (XSWX:ROG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:ROG) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBY:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.